Parkside Financial Bank & Trust Regenxbio Inc. Transaction History

Parkside Financial Bank & Trust

  • $621 Million
  • Q2 2024

A detailed history of Parkside Financial Bank & Trust transactions in Regenxbio Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 18 shares of RGNX stock, worth $174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 5 260.0%
Holding current value
$174
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
BUY
$11.51 - $21.53 $149 - $279
13 Added 260.0%
18 $0
Q1 2024

May 01, 2024
BUY
$12.17 - $24.61 $60 - $123
5 New
5 $0
Q3 2023

Nov 13, 2023
SELL
$16.46 - $19.99 $823 - $999
-50 Reduced 79.37%
13 $0
Q2 2023

Aug 15, 2023
BUY
$17.23 - $21.71 $999 - $1,259
58 Added 1160.0%
63 $1,000
Q1 2023

May 04, 2023
SELL
$18.08 - $24.55 $2,820 - $3,829
-156 Reduced 96.89%
5 $0
Q4 2022

Feb 13, 2023
BUY
$20.4 - $24.73 $2,060 - $2,497
101 Added 168.33%
161 $3,000
Q3 2022

Nov 01, 2022
BUY
$22.29 - $35.04 $200 - $315
9 Added 17.65%
60 $2,000
Q2 2022

Jul 13, 2022
SELL
$19.35 - $35.04 $696 - $1,261
-36 Reduced 41.38%
51 $1,000
Q1 2022

May 13, 2022
SELL
$24.62 - $34.31 $2,092 - $2,916
-85 Reduced 49.42%
87 $3,000
Q4 2021

Feb 14, 2022
BUY
$30.19 - $40.28 $1,267 - $1,691
42 Added 32.31%
172 $6,000
Q3 2021

Oct 29, 2021
SELL
$29.09 - $45.68 $1,861 - $2,923
-64 Reduced 32.99%
130 $5,000
Q2 2021

Aug 06, 2021
BUY
$32.46 - $40.48 $2,759 - $3,440
85 Added 77.98%
194 $8,000
Q4 2020

Feb 09, 2021
BUY
$26.52 - $49.35 $2,890 - $5,379
109 New
109 $5,000
Q3 2020

Nov 06, 2020
SELL
$27.01 - $40.26 $621 - $925
-23 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$27.75 - $43.44 $333 - $521
12 Added 109.09%
23 $1,000
Q1 2020

May 05, 2020
SELL
$21.5 - $54.2 $451 - $1,138
-21 Reduced 65.63%
11 $0
Q3 2019

Nov 05, 2019
SELL
$31.84 - $50.88 $413 - $661
-13 Reduced 28.89%
32 $1,000
Q1 2019

May 01, 2019
BUY
$40.82 - $62.45 $1,836 - $2,810
45 New
45 $3,000
Q4 2018

Jan 31, 2019
SELL
$39.11 - $75.15 $782 - $1,503
-20 Closed
0 $0
Q3 2018

Oct 12, 2018
BUY
$65.0 - $82.15 $65 - $82
1 Added 5.26%
20 $2,000
Q2 2018

Aug 03, 2018
BUY
$27.2 - $74.35 $516 - $1,412
19 New
19 $1,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $420M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email